The Array of Antibacterial Action of Protocatechuic Acid Ethyl Ester and Erythromycin on Staphylococcal Strains
Maria Miklasińska-Majdanik1, Małgorzata Kępa1, Monika Kulczak1
1Department of Microbiology and Virology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.
Abstract:
The spread of antibiotic resistance among bacteria has become one of the major health problems worldwide. Methicillin-resistant staphylococcal strains are especially dangerous because they are often resistant to other antibiotics. The increasing insensitivity to macrolides, lincosamides and streptogramin B antibiotics of methicillin-resistant staphylococcal isolates has limited the use of these drugs in therapy. The combination of natural compounds and antibiotics can be considered as an alternative tool to fight multi-drug-resistant pathogen infections. The aim of the presented study was to examine the antibacterial activity of protocatechuic acid ethyl ester-erythromycin combination towards Staphylococcus aureus and Staphylococcus epidermidis strains with various resistance profiles to methicillin and macrolides, lincosamides and streptogramin B (MLSB) antibiotics. The in-vitro antibacterial potential of the above combination was investigated by minimum inhibitory concentration assays and checkerboard testing. The observed effects were strain dependent, with 8 of 12 tested staphylococcal strains showing an indifferent effect on the natural compound and erythromycin; for 2 strains, the tested combination had an additive effect, while for another 2, the effect was synergistic. Interestingly, the multi-drug-resistant strains were more sensitive to the cooperative action of the protocatechuic acid ethyl ester and the antibiotic.
Insights
This study explored combining protocatechuic acid ethyl ester with erythromycin to combat antibiotic-resistant bacteria. The combination showed synergistic effects against some multi-drug-resistant staphylococcal strains, offering a potential new strategy.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotic resistance, particularly from methicillin-resistant staphylococcal strains, is a global health crisis.
- Resistance to macrolides, lincosamides, and streptogramin B (MLSB) limits treatment options for staphylococcal infections.
- Combining natural compounds with antibiotics presents a promising strategy against multi-drug-resistant pathogens.
Purpose of the Study:
- To evaluate the antibacterial activity of protocatechuic acid ethyl ester combined with erythromycin.
- To assess this combination against Staphylococcus aureus and Staphylococcus epidermidis strains with diverse resistance profiles.
- To investigate the synergistic, additive, or indifferent effects of the combination on bacterial growth.
Main Methods:
- In vitro antibacterial assays were performed.
- Minimum inhibitory concentration (MIC) determination was used.
- Checkerboard testing was employed to assess drug interactions.
Main Results:
- The combination's effect was strain-dependent.
- Synergistic effects were observed in 2 out of 12 tested staphylococcal strains.
- Multi-drug-resistant strains exhibited increased sensitivity to the protocatechuic acid ethyl ester-erythromycin combination.
Conclusions:
- Protocatechuic acid ethyl ester-erythromycin combination demonstrates potential as an alternative therapeutic approach.
- The combination shows promise in combating multi-drug-resistant staphylococcal infections.
- Further research into natural compound-antibiotic combinations is warranted.
More Related Videos
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
Related Concept Videos
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Phylum Actinobacteria
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
